COVID-19, a self-limiting disease – A case report of a severe COVID-19 pneumonia patient with multiple comorbidities successfully treated without antivirals

COVID-19 pneumonia is a communicable disease with no definite therapy. Therapeutic recommendations are still evolving based on ongoing studies and clinical trials. Patients with comorbidities, such as obesity and diabetes, are at risk for developing more severe diseases with higher mortality rates. A number of antivirals, such as oseltamivir, favipiravir, and remdesivir, have been proposed as a treatment for COVID-19, especially in severe diseases. However, the World Health Organization (WHO) initially does not recommend any antiviral therapy.